Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening

NACompletedINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Breast Cancer
Interventions
OTHER

Risk based screening

Breast cancer risk measurement, screening recommendations and shared decision making

Trial Locations (1)

25198

Institut de Recerca Biomèdica de Lleida, Lleida

All Listed Sponsors
collaborator

Institut Català de la Salut

OTHER

collaborator

Catalan Health Service

UNKNOWN

lead

Institut de Recerca Biomèdica de Lleida

OTHER

NCT03791008 - Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening | Biotech Hunter | Biotech Hunter